氯雷他定片剂一致性评价研究方法
Investigations on Consistency Evaluation for Loratadine Tablets
中文关键词  
DOI:
中文关键词:  氯雷他定片  仿制药  一致性评价  溶出曲线  生物等效性
英文关键词:loratadine tablet  generic drug  consistency evaluation  dissolution curve  bioequivalence
基金项目:
作者单位
陆依华 1,2 1. 中国药科大学药物质量与安全预警教育部重点实验室,江苏 南京 210009;2. 中国药科大学药物一致性评价重点实验室,江苏 南京 210009 
摘要点击次数: 255
全文下载次数: 296
中文摘要:
      为改善我国部分仿制药质量与国际先进水平还存在一定差距的现状,《国家药品安全“十二五”规划》中明确提出了开展仿制药一 致性评价,全面提高仿制药质量的任务。氯雷他定片作为抗过敏药物的主要品种之一,需在 2018 年底前完成一致性评价。基于现有质量和 疗效一致性评价指导原则与相关研究报道,针对氯雷他定原料药的晶型研究、原辅料杂质的比较研究、片剂溶出曲线的比较方法以及生物 等效性试验研究等进行了总结和概括,并对有待解决的共性问题进行了讨论。
英文摘要:
      In order to reduce the quality gap between some generic drugs in China and the international advanced level, “National Drug Safety ‘Twelfth Five-Year Plan’” clearly put forward the task of conducting consistency evaluation and improving the quality of generic drugs. Loratadine tablet is one of the major anti-allergic drugs, and its consistency evaluation needs to be completed before 2018. Based on the existing guidelines and research reports on quality and ef cacy consistency evaluation, this review summarized the study on polymorphism of loratadine bulk drug, comparative study of impurities in API and excipients, methods to compare dissolution curves of tablets and the study of bioequivalence test. Also, some common problems to be solved were discussed.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器
关闭